ROTATOR CUFF TENDINOPATHY
Clinical trials for ROTATOR CUFF TENDINOPATHY explained in plain language.
Never miss a new study
Get alerted when new ROTATOR CUFF TENDINOPATHY trials appear
Sign up with your email to follow new studies for ROTATOR CUFF TENDINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shoulder pain drug trial halted early – what happened?
Symptom relief TerminatedThis study tested whether secukinumab, an injected drug, could reduce pain and improve shoulder function in adults with moderate to severe rotator cuff tendinopathy (a common cause of shoulder pain). Participants received either the drug or a placebo, plus standard care, for 24 w…
Matched conditions: ROTATOR CUFF TENDINOPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 06:51 UTC
-
Shoulder pain drug trial halted early
Symptom relief TerminatedThis study tested whether secukinumab, an injected drug, could reduce pain and improve function in adults with moderate to severe rotator cuff tendinopathy (shoulder tendon pain). About 60 people were planned to receive either the drug or a placebo for 24 weeks. The trial was ter…
Matched conditions: ROTATOR CUFF TENDINOPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 06:46 UTC